Rapamycin for Prevention of Chronic Graft-Versus-Host Disease

NCT00623012 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Graft Versus Host Disease

Interventions

DRUG: Rapamycin
DRUG: Tacrolimus

Sponsor

Yale University